|
METTL9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.06990000001439E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04029999999467E-05 |
| Normal-vs-Stage2 |
5.848800E-04 |
| Normal-vs-Stage3 |
6.717500E-03 |
| Normal-vs-Stage4 |
7.425200E-04 |
| Stage1-vs-Stage2 |
6.176400E-01 |
| Stage1-vs-Stage3 |
2.113800E-01 |
| Stage1-vs-Stage4 |
5.071800E-01 |
| Stage2-vs-Stage3 |
1.737760E-01 |
| Stage2-vs-Stage4 |
8.996000E-01 |
| Stage3-vs-Stage4 |
1.388810E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.44099999999747E-05 |
| Normal-vs-AfricanAmerican |
1.016700E-03 |
| Normal-vs-Asian |
1.342270E-02 |
| Caucasian-vs-AfricanAmerican |
1.151780E-01 |
| Caucasian-vs-Asian |
5.790400E-01 |
| AfricanAmerican-vs-Asian |
9.191800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.632100E-04 |
| Normal-vs-Female |
4.63120000004924E-06 |
| Male-vs-Female |
7.595200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.58507999999946E-05 |
| Normal-vs-Age(41-60Yrs) |
5.75879999999973E-05 |
| Normal-vs-Age(61-80Yrs) |
2.902400E-03 |
| Normal-vs-Age(81-100Yrs) |
9.392000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.700400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.024800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.082160E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.612600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.088800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.726370E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.048400E-01 |
| Classical-VS-Follicular |
1.415670E-02 |
| Classical-VS-Other |
5.196800E-01 |
| Classical-VS-Normal |
2.17159999982286E-07 |
| Tall-VS-Follicular |
4.067000E-01 |
| Tall-VS-Other |
8.143600E-01 |
| Tall-VS-Normal |
5.484600E-03 |
| Follicular-VS-Other |
8.666200E-01 |
| Follicular-VS-Normal |
3.765600E-02 |
| Other-VS-Normal |
3.776200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.383700E-04 |
| Normal-vs-N1 |
5.297800E-02 |
| N0-vs-N1 |
4.636200E-01 |
|
|
